Pyrilutamide Phase 3 on its way
    Treatment 11/24/2021

    At a glance
    In this general discussion post, the primary subjects mentioned are
    πŸ’§ Pyrilutamide (topical) 5mg/ml once daily
    πŸ’§ Finasteride (topical) 0.25%
    πŸ’§ Minoxidil (topical) 5%
    πŸ’Š Dutasteride (oral)
    β€’ RU58841
    the tone is 😐 neutral.

    Other terms

    Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 745 results

    Related Research

    6 / 8 results